Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

17.5%

195 terminated/withdrawn out of 1117 trials

Success Rate

76.9%

-9.7% vs industry average

Late-Stage Pipeline

13%

145 trials in Phase 3/4

Results Transparency

54%

349 of 649 completed trials have results

Key Signals

144 recruiting349 with results130 terminated65 withdrawn

Enrollment Performance

Analytics

N/A
513(63.4%)
Phase 4
90(11.1%)
Phase 2
84(10.4%)
Phase 3
55(6.8%)
Phase 1
44(5.4%)
Early Phase 1
23(2.8%)
809Total
N/A(513)
Phase 4(90)
Phase 2(84)
Phase 3(55)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (1117)

Showing 20 of 1117 trials
NCT01815359Phase 2Active Not Recruiting

ICARuS Post-operative Intraperitoneal Chemotherapy (EPIC) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) After Optimal Cytoreductive Surgery (CRS) for Neoplasms of the Appendix, Colon or Rectum With Isolated Peritoneal Metastasis

Role: collaborator

NCT04598932Enrolling By Invitation

Corneal Biomechanical Analysis Using Brillouin Microscopy

Role: lead

NCT06795035Recruiting

Assessment of Coronary Microvascular Dysfunction After STEMI Using Continuous Saline Thermodilution

Role: lead

NCT05063331Not ApplicableActive Not Recruiting

Patient-Centered Outcomes in the Surgical Treatment of Uterovaginal Prolapse

Role: collaborator

NCT06854614Phase 4Active Not Recruiting

Sequential Therapy Anti-obesitY Medication With Muscle Preservation for Weight Loss and MaintEnance: A PragmAtic Randomized CoNtrolled Trial (STAY-LEAN Trial)

Role: lead

NCT06179654Not ApplicableActive Not Recruiting

Preoperative Pelvic Floor Physical Therapy to Minimize Stress Urinary Incontinence After Holmium Laser Enucleation of the Prostate

Role: lead

NCT07846566Not ApplicableNot Yet Recruiting

Choose Myself (Before) Losing Myself

Role: lead

NCT07060118Not ApplicableActive Not Recruiting

Gluten Free Diet in Hashimoto's Hypothyroidism

Role: lead

NCT05832229Phase 2Recruiting

Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States

Role: collaborator

NCT07650669Not Yet Recruiting

Wearable Technology in Heart Failure Patients

Role: lead

NCT06335719Not ApplicableRecruiting

Intraoperative Electrical Stimulation to Improve Nerve Grafting Outcome

Role: lead

NCT04869813Enrolling By Invitation

Sarcopenia Magnetic Resonance Imaging Evaluation (SUSIE)

Role: lead

NCT05166499Not ApplicableRecruiting

HMB Enriched Amino Acids to Reverse Muscle Loss in Cirrhosis

Role: lead

NCT07649148Not Yet Recruiting

Dietary Tracking in Heart Failure

Role: lead

NCT05982769Not ApplicableRecruiting

Molecular Mechanism of Exercise in Cirrhosis

Role: lead

NCT04858412Not ApplicableRecruiting

Study of HMB-enriched Amino Acid Supplementation in Patients With Alcoholic Liver Disease and COVID-19

Role: lead

NCT03224949Recruiting

Comparison of ALD, NASH, and Healthy Control Patients

Role: lead

NCT07770633Not ApplicableNot Yet Recruiting

Negative Pressure Wound Therapy Devices in Total Knee Arthroplasty

Role: lead

NCT03288025Not ApplicableActive Not Recruiting

Pulmonary Arterial Hypertension Improvement With Nutrition and Exercise (PHINE)

Role: lead

NCT04096014Not ApplicableRecruiting

Late Evening and Early Morning Protein Supplement to Reduce Readmissions for Hepatic Encephalopathy

Role: lead